Cargando…
Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review
OBJECTIVES: The article summarises the available guidelines on breast imaging surveillance after curative treatment for locoregional breast cancer. METHODS: A systematic review of practice guidelines published from 1 January 2007 to 1 January 2017 was performed according to PRISMA methodology. The s...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269345/ https://www.ncbi.nlm.nih.gov/pubmed/30411278 http://dx.doi.org/10.1007/s13244-018-0667-5 |
_version_ | 1783376463474458624 |
---|---|
author | Swinnen, Jeroen Keupers, Machteld Soens, Julie Lavens, Matthias Postema, Sandra Van Ongeval, Chantal |
author_facet | Swinnen, Jeroen Keupers, Machteld Soens, Julie Lavens, Matthias Postema, Sandra Van Ongeval, Chantal |
author_sort | Swinnen, Jeroen |
collection | PubMed |
description | OBJECTIVES: The article summarises the available guidelines on breast imaging surveillance after curative treatment for locoregional breast cancer. METHODS: A systematic review of practice guidelines published from 1 January 2007 to 1 January 2017 was performed according to PRISMA methodology. The search was conducted for the EMBASE, MEDLINE, Cochrane and Centre for Reviews and Dissemination databases. On 8 July 2018, all included guidelines were updated to the most recent version. RESULTS: Twenty-one guidelines originating from 18 publishing bodies matched criteria. Publishing bodies consisted of seven governmental institutions, nine medical societies and two mixed collaborations. Publishing boards consisted of six radiological, four oncological, and 11 multidisciplinary teams. Annual bilateral mammography surveillance after breast-conserving therapy was recommended by 17/18 (94.4%) publishing bodies. Annual contralateral mammography surveillance after mastectomy was recommended by 13/18 (72.2%) publishing bodies. Routine use of digital breast tomosynthesis was recommended by 1/18 (5.6%) publishing bodies. Routine breast ultrasound surveillance was recommended by 2/18 (11.1%), deemed optional by 4/18 (22.2%) and not supported by 8/18 (44.4%) publishing bodies. Routine breast magnetic resonance imaging (MRI) surveillance was not recommended by 16/18 (88.9%) publishing bodies, although 6/18 (33.3%) specified subgroups for systematic MRI surveillance. CONCLUSIONS: Annual mammography is currently the ‘gold standard’ for breast imaging surveillance. The role of digital breast tomosynthesis (DBT) remains to be further investigated. Most guidelines do not recommend routine breast ultrasound or MRI surveillance, unless indicated by additional risk factors. |
format | Online Article Text |
id | pubmed-6269345 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-62693452018-12-11 Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review Swinnen, Jeroen Keupers, Machteld Soens, Julie Lavens, Matthias Postema, Sandra Van Ongeval, Chantal Insights Imaging Review OBJECTIVES: The article summarises the available guidelines on breast imaging surveillance after curative treatment for locoregional breast cancer. METHODS: A systematic review of practice guidelines published from 1 January 2007 to 1 January 2017 was performed according to PRISMA methodology. The search was conducted for the EMBASE, MEDLINE, Cochrane and Centre for Reviews and Dissemination databases. On 8 July 2018, all included guidelines were updated to the most recent version. RESULTS: Twenty-one guidelines originating from 18 publishing bodies matched criteria. Publishing bodies consisted of seven governmental institutions, nine medical societies and two mixed collaborations. Publishing boards consisted of six radiological, four oncological, and 11 multidisciplinary teams. Annual bilateral mammography surveillance after breast-conserving therapy was recommended by 17/18 (94.4%) publishing bodies. Annual contralateral mammography surveillance after mastectomy was recommended by 13/18 (72.2%) publishing bodies. Routine use of digital breast tomosynthesis was recommended by 1/18 (5.6%) publishing bodies. Routine breast ultrasound surveillance was recommended by 2/18 (11.1%), deemed optional by 4/18 (22.2%) and not supported by 8/18 (44.4%) publishing bodies. Routine breast magnetic resonance imaging (MRI) surveillance was not recommended by 16/18 (88.9%) publishing bodies, although 6/18 (33.3%) specified subgroups for systematic MRI surveillance. CONCLUSIONS: Annual mammography is currently the ‘gold standard’ for breast imaging surveillance. The role of digital breast tomosynthesis (DBT) remains to be further investigated. Most guidelines do not recommend routine breast ultrasound or MRI surveillance, unless indicated by additional risk factors. Springer Berlin Heidelberg 2018-11-08 /pmc/articles/PMC6269345/ /pubmed/30411278 http://dx.doi.org/10.1007/s13244-018-0667-5 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Swinnen, Jeroen Keupers, Machteld Soens, Julie Lavens, Matthias Postema, Sandra Van Ongeval, Chantal Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review |
title | Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review |
title_full | Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review |
title_fullStr | Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review |
title_full_unstemmed | Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review |
title_short | Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review |
title_sort | breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269345/ https://www.ncbi.nlm.nih.gov/pubmed/30411278 http://dx.doi.org/10.1007/s13244-018-0667-5 |
work_keys_str_mv | AT swinnenjeroen breastimagingsurveillanceaftercurativetreatmentforprimarynonmetastasisedbreastcancerinnonhighriskwomenasystematicreview AT keupersmachteld breastimagingsurveillanceaftercurativetreatmentforprimarynonmetastasisedbreastcancerinnonhighriskwomenasystematicreview AT soensjulie breastimagingsurveillanceaftercurativetreatmentforprimarynonmetastasisedbreastcancerinnonhighriskwomenasystematicreview AT lavensmatthias breastimagingsurveillanceaftercurativetreatmentforprimarynonmetastasisedbreastcancerinnonhighriskwomenasystematicreview AT postemasandra breastimagingsurveillanceaftercurativetreatmentforprimarynonmetastasisedbreastcancerinnonhighriskwomenasystematicreview AT vanongevalchantal breastimagingsurveillanceaftercurativetreatmentforprimarynonmetastasisedbreastcancerinnonhighriskwomenasystematicreview |